FDA approved updated 2026-2027 COVID-19 vaccines from Pfizer-BioNTech, Moderna, and Novavax's partners, all reformulated to target the XFG variant, giving clinicians several options ahead of the fall respiratory virus season.
News|Videos|March 18, 2026
The Evolving Childhood Vaccine Schedule: Staying Atop the Shifting Vaccine Recommendations
Author(s)John Parkinson
In the final episode, the panelists offer some insights around following the federal agencies' ever-changing vaccine policies and the value of following professional medical societies' guidance during this period of uncertainty.
Advertisement
Advertisement
Our roundtable series, Clinical Insights: Childhood Vaccine Schedule Changes, discusses the ongoing changes being made to the pediatric vaccine schedule, the inner workings of the current Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), and how all of this is impacting US public health.
Related to this article
The Vaccine Integrity Project, in collaboration with the American Medical Association, conducted a vaccine and immunization effectiveness and safety review for RSV, Influenza, and COVID-19 for the 2026-2027 season. JAMA published the review, and here is an overview of the data going into this year's seasonal respiratory virus season.
Here is a comprehensive list of vaccines approved this year as well as background information on the clinical data for each of them.
The latest CDC numbers show a 5.4% increase of measles cases from week-to-week. This year has already become the worst for the number of measles cases in the US since the disease was declared eliminated in 2000. With the start of respiratory virus season, case numbers are expected to continue to increase significantly.
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
The 18-year old resident of the state suffered from acute disseminated encephalomyelitis. Pennsylvania numbers are surging with some of the highest state totals of measles cases in the country.
The death was reported in Jefferson County where the coroner released a statement announcing it was in an unvaccinated woman.
Advertisement
Advertisement